Research and Markets (http://www.researchandmarkets.com/research/xh7ns7/gouty_arthritis) has announced the addition of the "Gouty Arthritis (Gout) - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Gouty Arthritis (Gout), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gouty Arthritis (Gout) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Report Coverage
  3. Gouty Arthritis (Gout) Overview
  4. Therapeutics Development
  5. Pipeline Products for Gouty Arthritis (Gout) - Overview
  6. Pipeline Products for Gouty Arthritis (Gout) - Comparative Analysis
  7. Gouty Arthritis (Gout) - Therapeutics under Development by Companies
  8. Gouty Arthritis (Gout) - Therapeutics under Investigation by Universities/Institutes
  9. Gouty Arthritis (Gout) - Pipeline Products Glance
  10. Late Stage Products
  11. Clinical Stage Products
  12. Early Stage Products
  13. Unknown Stage Products
  14. Gouty Arthritis (Gout) - Products under Development by Companies
  15. Gouty Arthritis (Gout) - Products under Investigation by Universities/Institutes
  16. Gouty Arthritis (Gout) - Companies Involved in Therapeutics Development

Companies Mentioned

  • AstraZeneca Plc
  • Celtaxsys, Inc.
  • CymaBay Therapeutics, Inc.
  • Delenex Therapeutics AG
  • Immune Response BioPharma, Inc.
  • IOmet Pharma
  • JW Pharmaceutical Corporation
  • LG Life Science LTD.
  • Monosol Rx, LLC
  • Nimbus Therapeutics, LLC
  • Omni Bio Pharmaceutical Inc.
  • Opsona Therapeutics Limited
  • PLx Pharma Inc.
  • Polaris Pharmaceuticals, Inc.
  • Selecta Biosciences, Inc.
  • Takeda Pharmaceutical Company Limited
  • Teijin Limited
  • TWi Pharmaceuticals, Inc.
  • Wellstat Therapeutics Corporation

For more information visit http://www.researchandmarkets.com/research/xh7ns7/gouty_arthritis